Maryland

The Medicaid Pharmacy Program announced, effective Monday, January 28, Kapyay® ER will no longer be preferred over its generic equivalent. The current Preferred Drug List (PDL) is available on the website.

Also in Maryland…The Medicaid Pharmacy Program announced, effective Friday, February 15, Reyataz® capsules will no longer be preferred over its generic equivalent.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.